- Serum lipid profile abnormalities among beta-thalassemia patients: a systematic review and meta-analysis
Lipids in Health and Disease · 2024
- Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study
European Journal of Endocrinology · 2024
- Sleep disorders as risk factors for calcific aortic stenosis
2024
- Short-term incidence of dyslipidemia traits by urbanization and altitude: The CRONICAS Cohort Study
Wellcome Open Research · 2024
- Chronobiological disruptions: unravelling the interplay of shift work, circadian rhythms, and vascular health in the context of stroke risk
Clinical and Experimental Medicine · 2024
- Cross-sectional analysis of dyslipidemia risk in coal mine workers: from epidemiology to animal models
Scientific Reports · 2024
- Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis
International Journal of Cardiology · 2024
- ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients
Lipids in Health and Disease · 2024
- A European, Observational, 3‐Year Cohort Comparative Study on the Safety of the Fixed Dose Combination Pravastatin 40 mg/Fenofibrate 160 mg vs. Statin Alone in Real Clinical Practice: The <scp>POSE</scp> Study
Pharmacoepidemiology and Drug Safety · 2024
- The cardioprotective effects of Fruitflow® against Doxorubicin-induced toxicity in rat cardiomyoblast cells H9c2 (2−1) and high-fat diet-induced dyslipidemia and pathological alteration in cardiac tissue of Wistar Albino rats
Biomedicine & Pharmacotherapy · 2024
- An ensemble model for predicting dyslipidemia using 3-years continuous physical examination data
Frontiers in Physiology · 2024
- Role of gene polymorphism in the development of disorders of the lipid profile in individuals exposed to chemicals
Hygiene and Sanitation · 2024
- The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2
Cardiovascular Diabetology · 2024
- SHR-1918, a monoclonal antibody against angiopoietin-like 3, in healthy subjects: a randomized, double-blind, placebo-controlled, phase 1 study
European Heart Journal · 2024
- Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India
Journal of the Association of Physicians of India · 2024
- Impact of European Stroke Organisation secondary prevention guideline for ischaemic stroke / transient ischaemic attack
Journal of Stroke and Cerebrovascular Diseases · 2024
- The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study
Cardiovascular Diabetology · 2024
- Comparison of obesity indicators for predicting cardiovascular risk factors and multimorbidity among the Chinese population based on ROC analysis
Scientific Reports · 2024
- Pharmacokinetics and Safety of Pemafibrate in Patients with both Dyslipidemia and Severe Renal Impairment: A Phase 4 Study
Journal of Atherosclerosis and Thrombosis · 2024
- Expanding therapeutic options: overview of novel pharmacotherapies for dyslipidemia
Expert Opinion on Pharmacotherapy · 2024
- Cardiometabolic risk factors in women: what's sauce for the goose is not sauce for the gander
Current Opinion in Endocrinology Diabetes and Obesity · 2024
- Lipid profile and mortality in patients with pulmonary thromboembolism; a systematic review and meta-analysis
Journal of Basic and Clinical Physiology and Pharmacology · 2024
- Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
BMC Cardiovascular Disorders · 2024
- Circumventing Cardiovascular Calamities: The Dawn of ANGPTL3 Blockade in Severe Dyslipidemia Management
Cardiovascular & Haematological Disorders - Drug Targets · 2024
- Time-course atherogenic blood lipid response to statin discontinuation in dyslipidemic adults
Nutrition Metabolism and Cardiovascular Diseases · 2024
- Management of dyslipidemia in coronary artery disease: the present and the future
Coronary Artery Disease · 2024
- Modification of lipoprotein metabolism and function driving atherogenesis in diabetes
Atherosclerosis · 2024
- Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes
European Journal of Clinical Investigation · 2024
- Effects of Melissa officinalis (lemon balm) consumption on serum lipid profile: a meta-analysis of randomized controlled trials
BMC Complementary Medicine and Therapies · 2024
- Clinical impact of genetic testing for lipid disorders
Current Opinion in Cardiology · 2024
- Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil
Journal of clinical lipidology · 2024
- The impact of non-pharmacological interventions on adherence to medication and persistence in dyslipidaemia and hypertension: a systematic review
Expert Review of Pharmacoeconomics & Outcomes Research · 2024
- APOC3 siRNA and ASO therapy for dyslipidemia
Current Opinion in Endocrinology Diabetes and Obesity · 2024
- Treatment of dyslipidemia in acute coronary syndrome
Indian Heart Journal · 2024
- Dyslipidaemia in elderly and stroke patients
Indian Heart Journal · 2024
- Cardiovascular Risk Factors in China
Journal of Geriatric Cardiology · 2024
- Predicting the 10-year incidence of dyslipidemia based on novel anthropometric indices, using data mining
Lipids in Health and Disease · 2024
- Epidemiology of multimorbidity associated with atherosclerotic cardiovascular disease in the United States, 1999–2018
BMC Public Health · 2024
- Multimorbidity impacts cardiovascular disease risk following percutaneous coronary intervention: latent class analysis of the Melbourne Interventional Group (MIG) registry
BMC Cardiovascular Disorders · 2024
- Optimal Medical Therapy for Stable Ischemic Heart Disease in 2024
Medical Clinics of North America · 2024
- The chylomicron saga: time to focus on postprandial metabolism
Frontiers in Endocrinology · 2024
- Evaluation & Assessment of Chest Pain among Dyslipidemic Out-Door Patients without Prior Clinical Ischemic Heart Disease
Bangladesh Heart Journal · 2024
- Metabolic and bariatric surgery in patients with class I obesity; a two-year follow-up
BMC Surgery · 2024
- Prevalence and trend of multiple coronary artery disease risk factors and their 5-year incidence rate among adult population of Kerman: results from KERCADR study
BMC Public Health · 2024
- Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Journal of Lipid and Atherosclerosis · 2024
- Lipid Profile of Patients Seen in Consultation at the Cardiology Department at the Ignace DEEN National Hospital (City of Conakry, Republic of Guinea)
Open Journal of Endocrine and Metabolic Diseases · 2024
- Burden of comorbidities in heart failure patients in Türkiye
TURKISH JOURNAL OF MEDICAL SCIENCES · 2024
- Association of carotid intima–media thickness and dyslipidaemia in patients with type 2 diabetes: a protocol for systematic review and meta-analysis
BMJ Open · 2024
- Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III
Cardiology · 2024
- Statistically verified methods for determining predictors of development of arterial hypertension depending on endothelial nitric oxide synthase T786C gene promoter polymorphism using lipid profile indicators
Endocrine Regulations · 2024